Browsing by Author "b7798852-ad60-439d-ba55-79adfce26c4a"
Now showing items 1-3 of 3
-
Alzheimer's disease susceptibility gene Apolipoprotein E (APOE) and blood biomarkers in UK Biobank (N = 395,769)
Ferguson, Amy C.; Tank, Rachana; Lyall, Laura M.; Ward, Joey; Celis-Morales, Carlos; Strawbridge, Rona; Ho, Frederick; Whelan, Christopher D.; Gill, Jason M.R.; Welsh, Paul; Anderson, Jana J.; Mark, Patrick B.; Mackay, Daniel; Smith, Daniel J.; Pell, J.P.; Cavanagh, Jonathan; Sattar, Naveed; Lyall, Donald (2020)Background: Alzheimer's disease (AD) is a neurodegenerative condition where the underlying etiology is still unclear. Investigating the potential influence of apolipoprotein E (APOE), a major genetic risk factor, on common ...
-
Child maltreatment and cardiovascular disease: quantifying mediation pathways using UK biobank
Ho, Frederick; Celis-Morales, Carlos; Gray, S.R.; Petermann-Rocha, Fanny; Lyall, Donald; Mackay, Daniel; Sattar, Naveed; Minnis, Helen; Pell, J.P. (2020)Background: Child maltreatment is associated with cardiovascular disease (CVD), but mediation pathways have not been fully elucidated. The aim of the current study was to determine and quantify the underlying pathways ...
-
Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: a prospective study from UK biobank
Petermann-Rocha, Fanny; Ho, Frederick; Welsh, Paul; Mackay, Daniel; Brown, Rosemary E.; Gill, Jason M.R.; Sattar, Naveed; Gray, S.R.; Pell, J.P.; Celis-Morales, Carlos (2020)Introduction: It is unclear what combinations of physical capability markers used to define sarcopenia have the strongest associations with health outcomes. Aim: To compare the associations between different combinations ...